Navigation Links
MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas
Date:1/7/2008

edical director/head of clinical development, rounds out the MedImmune Ventures team as senior vice president.

About MedImmune Ventures

MedImmune Ventures is a corporate venture capital fund with $300 million under management that invests in early-to late-stage, public or private biopharmaceutical companies focused on discovering and developing human therapeutics. The primary strategic areas of interest are antibodies and peptides/proteins, other various biologics, small molecules and vaccines. MedImmune Ventures will also examine investment opportunities related to new technologies and programs related to translational sciences, and the intersection between diagnostics and drug development. Investments range from seed funding through public investments in private equity.

Created to promote entrepreneurship and to give MedImmune early access to the newest companies and discoveries, MedImmune Ventures leverages a broad base of internal resources with expertise ranging from R&D to marketing of biologics and small molecules, which closely guide its investment strategies. The fund has provided MedImmune with early exposure to new technologies and therapeutic approaches and the opportunity to establish relationships that have eventually led to R&D collaborations and acquisitions. Now as a part of AstraZeneca, the fund will seek to continue implementing its investment plan while broadening its investment interests and leveraging the parent company's internal resources as well as its relationships with academic institutions, other biotechnology companies and worldwide venture capital firms.

Parties interested in seeking funding should direct inquiries to medimmuneventures@medimmune.com.

About MedImmune

MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. With approximately 3,000 employees worldwide and headquarters in Maryland, MedImmune is dedicated to ad
'/>"/>

SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
2. MedImmune Celebrates Opening of New Pilot Lab at Gaithersburg Headquarters
3. MedImmune Recognized by Local Volunteer Organization for Its Employees Exceptional Commitment to Community Service within Montgomery County
4. MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition
5. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
6. MedImmune Announces Seven Key Promotions and New Hires
7. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
8. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
9. PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
10. International Scientific Workshop Focuses on New Methods for Vaccine and Antibody Development
11. Pharmaceutical Product Launch: Commercially Focused R&D Increases Drugs Market Potential
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... 2015  Platform therapeutic company Symic Biomedical, Inc. ... $1.5M Phase II SBIR grant from the National ... therapeutic agent to reduce arteriovenous fistula (AVF) failures, ... renal disease (ESRD) patients undergoing hemodialysis. The two-year ... and Digestive and Kidney Diseases (NIDDK), will allow ...
(Date:8/26/2015)... , Aug. 26, 2015 China Cord Blood ... China,s leading provider of cord blood collection, ... storage services, today announced that the Company has been ... an entity wholly owned by Mr. Yuen Kam, chairman ... acquired the outstanding shares (the "Shares") of  Excellent China ...
(Date:8/26/2015)... San Bruno, CA. (PRWEB) , ... August 26, 2015 , ... ... three major conferences to develop new business relationships with local sponsors in southern California. ... services to facilitate their drug development processes and regulatory pathways., , ...
(Date:8/25/2015)... CARDIFF, UK (PRWEB) , ... August 25, 2015 ... ... accurately determining whether breast tissue lesions are cancerous is described by University of ... the international society for optics and photonics. , In “ Breast cancer diagnosis ...
Breaking Biology Technology:Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 3PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 3New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 2New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 3New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 4
... Key Data are New Releases for the Company ... Technology Discoveries --DENVER, April 20 DXL625 ... commercial-stage antibodies in their ability to attach and ... to research conducted at InNexus Biotechnology Inc. (Toronto ...
... largest independent dermatology company, acquired by GSK in ... business will have combined revenues of approximately $1.5 ... to grow and diversify GSK,s business, providing immediate ... GlaxoSmithKline plc (NYSE: GSK ) and ...
... Terrorist organizations sometimes have an advantage in the media. ... University of Haifa, published in the journal of Israel,s ... the advantage in this arena too. , ... against terrorist organizations, sometimes more so than conventional weapons. ...
Cached Biology Technology:AACR 100th Annual Meeting Highlights Superior Ability of InNexus' DXL-Modified Anti-CD20 Antibody to Attach and Kill NHL With Safety Comparable to Approved Antibody Therapies in Preclinical Studies 2AACR 100th Annual Meeting Highlights Superior Ability of InNexus' DXL-Modified Anti-CD20 Antibody to Attach and Kill NHL With Safety Comparable to Approved Antibody Therapies in Preclinical Studies 3GlaxoSmithKline and Stiefel to Create New World-Leading Specialist Dermatology Business 2GlaxoSmithKline and Stiefel to Create New World-Leading Specialist Dermatology Business 3GlaxoSmithKline and Stiefel to Create New World-Leading Specialist Dermatology Business 4Information warfare in the 21st century: Ideas are sometimes stronger than bombs 2
(Date:8/18/2015)... Aug. 17, 2015 Research and Markets ... the "Global Biometric Authentication & Identification Market: ... & Forecast, 2015-2020" report to their offering. ... identification systems market is expected to grow at ... 2020 and generate over $25 billion (approximately) by ...
(Date:8/12/2015)... 12, 2015   MedNet Solutions , an innovative ... of clinical research, is proud to announce that ... SaaS-based eClinical technology platform, has led the way to ... quarters of 2015.   Q2 2015 and Q1 2015 ... by contract value sold in the company,s 15 year ...
(Date:8/12/2015)... NEW YORK , Aug. 12, 2015 /PRNewswire/ ... how hackers can attack Android phones to steal ... identifies the increasing availability of fingerprint scanners on ... of utmost concern. To secure biometrics on mobile ... platform to augment these convenient authentication systems with ...
Breaking Biology News(10 mins):Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2MedNet Solutions Experiences Explosive Corporate Growth 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3
... afternoon in Etosha National Park in northern Namibia, ... for elephants. "It's so fantastic here," she says. ... Garden of Eden." , A research associate in ... come to one of Africa's premiere wildlife sanctuaries ...
... Pratt School of Engineering have created a new three-dimensional ... probe creates a picture of the whole heart in ... image a single heart cross section. , The new ... condition of the heart, but also for use in ...
... Nervous system development requires billions of neurons to migrate to ... (axons) that connect to other nerve cells in an intricate ... are responsible for steering axons in the right direction, guided ... along the way. Some signals lure the axons to extend ...
Cached Biology News:Scientists journey to southern Africa to unravel the secret world of elephant communication 2Scientists journey to southern Africa to unravel the secret world of elephant communication 3Scientists journey to southern Africa to unravel the secret world of elephant communication 4Scientists journey to southern Africa to unravel the secret world of elephant communication 5Scientists journey to southern Africa to unravel the secret world of elephant communication 6Scientists journey to southern Africa to unravel the secret world of elephant communication 7Scientists journey to southern Africa to unravel the secret world of elephant communication 8Scientists journey to southern Africa to unravel the secret world of elephant communication 9Scientists journey to southern Africa to unravel the secret world of elephant communication 10Scientists journey to southern Africa to unravel the secret world of elephant communication 11Scientists journey to southern Africa to unravel the secret world of elephant communication 12Duke engineers develop new 3-D cardiac imaging probe 2Cerebral navigation: How do nerve fibers know what direction to grow in? 2
PCR System for increased fidelity, yield and length of PCR products. Amplifies targets up to 10 kb from human genomic DNA....
...
US Pharmacopoeia Purified-Water/Water-for-Injection Quality Water...
Immunogen: Secretory component isolated from human colostrum. Storage: 4 C...
Biology Products: